Article Details

Biogen sales face pressure from slow uptake of Alzhiemer's drug

Retrieved on: 2021-10-20 00:34:17

Tags for this article:

Click the tags to see associated articles and topics

Biogen sales face pressure from slow uptake of Alzhiemer's drug. View article details on hiswai:

Excerpt

... of $2.67 billion when it reports third-quarter results on Oct. 20, according to the mean estimate from 25 analysts, based on Refinitiv data​.

Article found on: whtc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up